Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. biopolymers
Show results for
Products
Services
Training
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Biopolymers Articles & Analysis

26 news found

Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhanced Drug Delivery Systems   

Protheragen-ING Provides Comprehensive Microneedle Technology Solutions to Achieve Enhanced Drug Delivery Systems  

In today’s evolving pharmaceutical landscape, the search for new drug delivery systems (DDS) is of paramount importance to improving therapeutic outcomes. With cutting-edge solutions in the field of microneedle technology, Protheragen-ING is on the front lines in this field. As a certified ISO9001 supplier of pharmaceutical ingredients and specialty chemicals, Protheragen-ING keeps ...

ByProtheragen-ING


Liposomes for Food Applications

Liposomes for Food Applications

It has been documented that liposome encapsulation is an enhancement strategy that can be developed alongside emulsions, microemulsions and biopolymer-based systems to develop newer and better formulations in the food field. ...

ByCD Bioparticles


CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles Announces Expanded Offerings of Polydimethylsiloxane for Cutting-Edge Research

CD Bioparticles offers various Biopolymers & Synthetic Polymers for customers worldwide. CD Bioparticles is committed to easing the burden on its customers by reducing cumbersome chemical synthesis, formulation and purification, improving drug loading efficiency and yield of drug delivery materials, and helping customers track and image the distribution of polymer-based ...

ByCD Bioparticles


CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications

CD Bioparticles Launches Locust Bean Gum for Biopharmaceutical Applications

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has launched a new line of Locust Bean Gum with advanced technical platforms to help scientists advance biopharmaceutical research. Over the past few decades, researchers have been working on developing delivery systems that can reduce side effects while improving efficacy. Natural polymers are ...

ByCD Bioparticles


CD Formulation Plays a Role in Developing Drug Delivery Systems

CD Formulation Plays a Role in Developing Drug Delivery Systems

Always at the forefront of innovation, CD Formulation continues to be a trustworthy CRO partner for pharmaceutical companies around the world. With unstopping efforts to expand its service portfolio, earlier this month, CD Formulation proudly announced the launch of drug delivery system development services, a move made not only to meet customers' drug development needs but also to exceed their ...

ByCD Formulation


BOC Sciences Yields Peptide-siRNA Conjugates of High Quality

BOC Sciences Yields Peptide-siRNA Conjugates of High Quality

Upon isolation and purification of conjugates, each biopolymer may move on to further sequence integrity monitoring via PAGE or mass spectrometry analysis. ...

ByBOC Sciences


CD Bioparticles Introduces the Launch of Alginates for Drug Delivery Research

CD Bioparticles Introduces the Launch of Alginates for Drug Delivery Research

CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of alginates products to support drug delivery research. They can be labeled with biotin or functionalized with amine groups, and are for laboratory research use only. Alginates are natural polymers composed of linear copolymers of ß-(1-4)-linked d-mannuronic acid and ...

ByCD Bioparticles


CD Bioparticles Launches Dendrons for Drug Delivery Research

CD Bioparticles Launches Dendrons for Drug Delivery Research

CD Bioparticles, a leading manufacturer and supplier of various drug delivery products and services, now introduces a series of dendrons products to support drug delivery research, such as DMPA-G1-Acetylene-NHBOC, DMPA-G1-Azide-NHBoc, and DMPA-G1-Biotin-Carboxyl. They can be used in theranostics, biosensors, optics, adhesives and coatings. CD Bioparticles has expanded its product offering, and ...

ByCD Bioparticles


CD Bioparticles Launches Heparins for Drug Delivery Research

CD Bioparticles Launches Heparins for Drug Delivery Research

In combination with CD Bioparticles’ other biopolymers & synthetic polymers products with customized delivery strategies, precise designs and modifications of drugs or drug-contained cargo, and advanced technical platforms, CD Bioparticles can help scientists to solve many tedious problems faced in the research process, such as limited options for material ...

ByCD Bioparticles


Alfa Chemistry Materials Presents Itself as a New Supplier of Biomaterials

Alfa Chemistry Materials Presents Itself as a New Supplier of Biomaterials

Biomaterials available at Alfa Chemistry Materials: Biocompatible Ceramics Bioelectronic Materials Crosslinkers Hydrogels and Crosslinked Polymers Hydrophilic Polymers Hydrophobic Polymers Natural Polymers and Biopolymers Oligonucleotide Polymers and Copolymers PEG-PPG Copolymers Poly(ethylene glycol) and Poly(ethylene oxide) Biodegradable Polymers Polyamino Acids Polysaccharide ...

ByAlfa Chemistry


TISSIUM selected for the French Tech 120 Program

TISSIUM selected for the French Tech 120 Program

About Tissium TISSIUM, a privately-owned medtech company based in Paris, France and Boston, USA is dedicated to the development and commercialization of products derived from its unique biopolymer platform. The company’s products will address multiple unmet clinical needs, including atraumatic tissue repair and reconstruction. ...

ByTISSIUM


TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy

TISSIUM Appoints Ruth Krestin as Vice President of Portfolio Strategy

TISSIUM has made incredible advancements with its unique biopolymer platform and I look forward to contributing to the development and commercialization of its pipeline of products.” About TISSIUM: TISSIUM, a privately-owned medtech company based in Paris, France and Boston, USA, is dedicated to the development and commercialization of products derived from its unique ...

ByTISSIUM


KiOmed Pharma and Sinclair Pharma sign an exclusive partnership based on “KiOmedine” technology

KiOmed Pharma and Sinclair Pharma sign an exclusive partnership based on “KiOmedine” technology

KiOmed Pharma focuses on the development, manufacturing and marketing of safe and effective medical devices and therapeutic solutions based on KiOmedine®, an innovative and exclusive animal-free chitosan biodegradable biopolymer. KiOmed Pharma offers a unique pipeline of products for tackling invalidating osteoarthritis, skin aging and dry eye ...

ByKiOmed Pharma


TISSIUM to present study results at the Hernia 2021 European Hernia Society - American Hernia Society Joint Congress

TISSIUM to present study results at the Hernia 2021 European Hernia Society - American Hernia Society Joint Congress

TISSIUM is developing a portfolio of productsthat leverage its unique biopolymer platform based on a novel biocompatible, biomorphic and biodegradable material, which is a highly viscous, light-activated surgical adhesive. ...

ByTISSIUM


TISSIUM to present study results at the 76th Annual Meeting of the American Society for Surgery of the Hand

TISSIUM to present study results at the 76th Annual Meeting of the American Society for Surgery of the Hand

TISSIUM is developing a portfolio of productsthat leverage its unique biopolymer platform based on a proprietary biocompatible, biomorphic and biodegradable material, which is a viscous, light-activated surgical adhesive. ...

ByTISSIUM


TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage

TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage

” ABOUT TISSIUM: TISSIUM is a privately-owned medtech company based in Paris, France and Boston, USA that is dedicated to the development and commercialization of a unique biopolymer platform to address multiple unmet clinical needs, including atraumatic tissue repair and reconstruction. ...

ByTISSIUM


KiOmed Pharma and moveUP Partner to Develop and Market a Companion Healthcare Application for Personalised Treatment of Osteoarthritis

KiOmed Pharma and moveUP Partner to Develop and Market a Companion Healthcare Application for Personalised Treatment of Osteoarthritis

KiOmed Pharma focuses on the development, manufacturing and marketing of safe and effective medical devices and therapeutic solutions based on KiOmedine®, an innovative and exclusive animal-free chitosan biodegradable biopolymer. KiOmed Pharma offers a unique pipeline of products for tackling invalidating osteoarthritis, skin aging and dry eye syndrome. ...

ByKiOmed Pharma


KiOmed Pharma reports promising long-term results in a new European multi centric survey Treatment of Advanced Knee OsteoArthritis

KiOmed Pharma reports promising long-term results in a new European multi centric survey Treatment of Advanced Knee OsteoArthritis

KiOmed Pharma focuses on the development, manufacturing and marketing of safe and effective medical devices and therapeutic solutions based on KiOmedine®, an innovative and exclusive animal-free chitosan biodegradable biopolymer. KiOmed Pharma offers a unique pipeline of products for tackling invalidating osteoarthritis, skin aging and dry eye ...

ByKiOmed Pharma


Chitosan as protection against dental erosion

Chitosan as protection against dental erosion

Chitosan has promising properties to improve the effectiveness of F/Sn toothpaste, as the biopolymer forms a protective layer on the tooth surface. The aim of the study was to investigate whether chitosan increases the anti-erosive efficacy of fluorine/tin-containing toothpastes and the influence of viscosity. ...

ByHeppe Medical Chitosan GmbH


TISSIUM Selected for French Tech 120 Program

TISSIUM Selected for French Tech 120 Program

About TISSIUM TISSIUM is a privately-owned medtech company based in Paris, France that is dedicated to the rapid development and commercialization of a unique biopolymer platform to address various unmet clinical needs. The company’s platform is based on a proprietary polymer family with unique properties including the ability to conform to and integrate with surrounding ...

ByTISSIUM

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT